NFKB1 and myasthenia gravis: Dang Gui Shao Yao San (Li et al., 2023): It has been found to inhibit the activation of MG by regulating the TLR4/MyD88/NF-κB signaling pathway, thereby inhibiting neuroinflammatory responses and playing a neuroprotective role.